Vaccinia virus tiantan strain is inefficient in eliciting cross-reactive immunity against the emerging monkeypox virus strain
Main Authors: | Lingqian Tian, Yongli Zhang, Qiuhong Liu, Lianguo Ruan, Fuli Ren, Yang Han, Yanfang Zhang, Lei Yang, Sha Li, Hao Sun, Yecheng Zhang, Yuan Zhou, Rongjuan Pei, Fei Deng, Chaolin Huang, Xinwen Chen, Yun Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2024-12-01
|
Series: | Emerging Microbes and Infections |
Online Access: | https://www.tandfonline.com/doi/10.1080/22221751.2024.2306967 |
Similar Items
-
Long-lasting humoral and cellular memory immunity to vaccinia virus Tiantan provides pre-existing immunity against mpox virus in Chinese population
by: Min Li, et al.
Published: (2024-01-01) -
Non-replicating Vaccinia Virus TianTan Strain (NTV) Translation Arrest of Viral Late Protein Synthesis Associated With Anti-viral Host Factor SAMD9
by: Ying Zhao, et al.
Published: (2020-03-01) -
Vaccinia-Virus-Based Vaccines Are Expected to Elicit Highly Cross-Reactive Immunity to the 2022 Monkeypox Virus
by: Syed Faraz Ahmed, et al.
Published: (2022-09-01) -
Monkeypox virus quadrivalent mRNA vaccine induces immune response and protects against vaccinia virus
by: Ye Sang, et al.
Published: (2023-04-01) -
Construction of three strains of recombinant oncolytic vaccinia virus and their anti-tumor activity
by: LI Dan-yang, FANG Jing-jing, TANG Hui
Published: (2020-04-01)